Compare OLMA & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OLMA | VIRT |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.8B |
| IPO Year | 2020 | 2015 |
| Metric | OLMA | VIRT |
|---|---|---|
| Price | $28.17 | $33.32 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 7 |
| Target Price | $40.50 | ★ $41.43 |
| AVG Volume (30 Days) | ★ 3.4M | 906.6K |
| Earning Date | 11-10-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 2.84% |
| EPS Growth | N/A | ★ 132.69 |
| EPS | N/A | ★ 4.62 |
| Revenue | N/A | ★ $2,694,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.33 |
| Revenue Growth | N/A | ★ 41.05 |
| 52 Week Low | $2.86 | $31.89 |
| 52 Week High | $36.26 | $45.77 |
| Indicator | OLMA | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 56.71 | 39.32 |
| Support Level | $25.62 | $33.30 |
| Resistance Level | $36.26 | $34.52 |
| Average True Range (ATR) | 2.76 | 0.84 |
| MACD | -0.80 | -0.17 |
| Stochastic Oscillator | 23.97 | 13.31 |
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.